Global Ablation Technologies Market Research Report 2021
Ablation Technologies is the treatment that destroys tumors or unwanted material without affecting other body tissues or organs. Because of poor health or reduced organ function, these techniques are widely used to treat cancer, cardiovascular and other chronic diseases. In the treatment of chronic diseases, medical ablation plays the prime role in the removal or complete destruction of abnormal tissue. Medical ablation can be done without surgery by insertion of the probe or a needle through the skin into the tumor. Ablation refers to a minimally invasive surgical procedure for the destruction or removal of abnormal tissues that can cause life-threatening conditions such as cancer, atrial fibrillation, and others. The most common types of cancers treated by medical ablation are kidney (renal) cancer, liver cancer, and lung cancer.
The ablation technologies market, by type is segmented into Radiofrequency, Laser/Light, Cryoablation, Microwave, Hydrothermal and others ablation technology. In 2017, Radiofrequency is the largest market share with 54.7%, The microwave ablation technology segment is estimated to grow at the highest CAGR during 2018 to 2023.
The market by application Cardiovascular Disease, Cancer, Ophthalmology, Pain Management, Gynecology, Orthopedic Treatment, and others. The cancer segment is expected to command a major share of the ablation technologies market in 2017 with the market share 45.4%.
North America is the largest consumption place, with a consumption market share nearly 41.7% in 2017. Following North America; Europe is the second largest consumption place with the consumption market share of 28.3% in 2017. Ablation Technologies market in Asia Pacific region is expected to exhibit the highest growth rate especially in the developing Asian countries like China & India.
Market competition is intense. Medtronic, AtriCure, Dornier MedTech, Boston Scientific, AngioDynamics, etc. are the leaders of the industry. And there will be more demand in this industry and more companies enter into this industry.
As per statistics from the World Health Organization, almost 17 million deaths each year are associated with cardiovascular diseases, of which atrial defibrillation is a major disorder. Moreover, the incidence of atrial fibrillation increases with age, attacking almost 1 out of every 20 people aged 65 and above.
Further, according to WHO statistics, in 2012, above 14 million people across the world were reported to have developed new types of cancer, about 32 million people were reported to be living with different type of cancers and more than 8 million deaths were associated with cancer across the globe. As such, the consistent rise in the patient pool of cancer and cardiovascular diseases will lead to significant demand for ablation devices in the forthcoming years.
The global Ablation Technologies market was 2790 million US$ in 2018 and is expected to 5720 million US$ by the end of 2025, growing at a CAGR of 9.4% between 2019 and 2025.
The global Ablation Technologies market was valued at US$ 3364.1 million in 2019 and is expected to reach US$ 6352.7 million by the end of 2026, growing at a CAGR of 9.4% during 2021-2026.
This report focuses on Ablation Technologies volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Ablation Technologies market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Ablation Technologies Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Radiofrequency Ablation
Laser/Light Ablation
Cryoablation Ablation
Microwave Ablation
Hydrothermal Ablation
Others
Segment by Application
Cardiovascular Disease
Cancer
Ophthalmology
Pain Management
Gynecology
Orthopedic Treatment
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Medtronic
AtriCure
Dornier MedTech
Boston Scientific
AngioDynamics
Lumenis
Abbott
Smith & Nephew
Olympus
Johnson & Johnson
EDAP TMS
Hologic
IRIDEX
CONMED
Merit Medical
The ablation technologies market, by type is segmented into Radiofrequency, Laser/Light, Cryoablation, Microwave, Hydrothermal and others ablation technology. In 2017, Radiofrequency is the largest market share with 54.7%, The microwave ablation technology segment is estimated to grow at the highest CAGR during 2018 to 2023.
The market by application Cardiovascular Disease, Cancer, Ophthalmology, Pain Management, Gynecology, Orthopedic Treatment, and others. The cancer segment is expected to command a major share of the ablation technologies market in 2017 with the market share 45.4%.
North America is the largest consumption place, with a consumption market share nearly 41.7% in 2017. Following North America; Europe is the second largest consumption place with the consumption market share of 28.3% in 2017. Ablation Technologies market in Asia Pacific region is expected to exhibit the highest growth rate especially in the developing Asian countries like China & India.
Market competition is intense. Medtronic, AtriCure, Dornier MedTech, Boston Scientific, AngioDynamics, etc. are the leaders of the industry. And there will be more demand in this industry and more companies enter into this industry.
As per statistics from the World Health Organization, almost 17 million deaths each year are associated with cardiovascular diseases, of which atrial defibrillation is a major disorder. Moreover, the incidence of atrial fibrillation increases with age, attacking almost 1 out of every 20 people aged 65 and above.
Further, according to WHO statistics, in 2012, above 14 million people across the world were reported to have developed new types of cancer, about 32 million people were reported to be living with different type of cancers and more than 8 million deaths were associated with cancer across the globe. As such, the consistent rise in the patient pool of cancer and cardiovascular diseases will lead to significant demand for ablation devices in the forthcoming years.
The global Ablation Technologies market was 2790 million US$ in 2018 and is expected to 5720 million US$ by the end of 2025, growing at a CAGR of 9.4% between 2019 and 2025.
The global Ablation Technologies market was valued at US$ 3364.1 million in 2019 and is expected to reach US$ 6352.7 million by the end of 2026, growing at a CAGR of 9.4% during 2021-2026.
This report focuses on Ablation Technologies volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Ablation Technologies market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Ablation Technologies Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Radiofrequency Ablation
Laser/Light Ablation
Cryoablation Ablation
Microwave Ablation
Hydrothermal Ablation
Others
Segment by Application
Cardiovascular Disease
Cancer
Ophthalmology
Pain Management
Gynecology
Orthopedic Treatment
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Medtronic
AtriCure
Dornier MedTech
Boston Scientific
AngioDynamics
Lumenis
Abbott
Smith & Nephew
Olympus
Johnson & Johnson
EDAP TMS
Hologic
IRIDEX
CONMED
Merit Medical
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
